AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Arthroscopic Rotator Cuff Repair with UC-MSCs for Large to Massive Tears

RecruitingNAAges 19 Years - anyAllKorea University Anam Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Safety Analysis of Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells in Patients Undergoing Rotator Cuff Repair for Massive or Large Rotator Cuff Tears

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Male or female 19 years of age and older * Unilateral shoulder pain with a pain score of 4 or higher. * patients with a symptom duration of at least three months who have not responded to conventional treatments, including analgesics. * patients diagnosed with massive or extensive full-thickness rotator cuff tears confirmed by computed tomography arthrography or magnetic resonance imaging. Exclusion Criteria: * patients diagnosed with small or medium full-thickness rotator cuff tears among study participants with full-thickness rotator cuff tears. * patients who have received subacromial injection therapy in the affected shoulder within the past three months. * patients who have undergone rotator cuff surgery on the affected shoulder within the past six months. * patients exhibiting or suspected of having the following radiological findings: malignant tumors, severe glenohumeral osteoarthritis, or bony abnormalities causing subacromial space narrowing. * patients presenting with symptomatic cervical spine disorders. * patients experiencing bilateral shoulder pain. * patients diagnosed with multiple arthritis, infectious arthritis, rheumatoid arthritis, or fibromyalgia. * patients with neurological deficits. * Pregnant or breastfeeding patients * patients unwilling to use effective contraception during the study period. * patients currently infected with HBV, HCV, or HIV, or those with a positive RPR test result. * patients with severe conditions that may affect the study, including cardiovascular diseases, renal diseases, hepatic diseases, endocrine disorders, or malignancies. * patients who are unable to comprehend the questionnaires used for study assessments, including the Visual Analog Scale (VAS), or those with communication difficulties due to psychiatric disorders. * Any other cases deemed inappropriate for study participation by the investigator.
๐Ÿ’Š

What it tests

  • Injection allogenic Umbilical Cord-derived Mesenchymal Stem Cell
๐Ÿ“

Where

1 site
Korea University Anamh Hospital
Seoul, South Korea
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy